Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Trichoscopy helps quickly identify autoimmune diseases on the scalp but should be used with other standard tests.

Gamma/delta T cells help defend skin against heavy metals.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Alopecia areata is an autoimmune disease that targets hair follicles.

Dermatologists should consider alpha-gal syndrome in patients with unexplained chronic skin issues.

People with alopecia areata are more likely to have other immune-related conditions.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

T cells show stress responses in alopecia areata, suggesting potential treatment targets.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

The LMNA mutation affects skin structure even in asymptomatic carriers.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Hair follicles in mice help detect and respond to germs.

The document concludes that MGRN1 affects mouse fur color by interfering with a receptor's signaling, but its full role in the body is still unknown.